Pharmacodynamics, pharmacokinetics, and safety of the oral reversible P2Y12 antagonist AZD6140 with aspirin in patients with atherosclerosis: a double-blind comparison to clopidogrel with aspirin.

By S. Husted, H. Emanuelsson, S. Heptinstall, P. Sandset, M. Wickens, G. Peters. European Heart Journal, 2006

771 citations recorded by the source corpus.